Why can’t I find anything negative to post about cannabis 
You can make a lot of money on penny stock but usually you have to trade or wait for years and cross your fingers and hope all goes to plan.
I bought KNB in December and January 2022-2023 after years of not investing in shares. My posting history will show that to be the case.
Buying half a million around the 2p mark and selling when it hit 4p.
I will admit it was good fortune as the only reason I came back to the stock market was because I was desperate financially, that uplift in share price literally saved me from losing my home. So nobody should follow my example unless like me they want to take a high risk punt.
Having seen what KNB were doing I decided to buy back.
Let’s hope the silence is broken soon with some positive updates.
1 Like
I made a few quid on these on last year’s spike.
Of all my portfolio, the two AIM stocks I own are the dogs. Due to all the capital outflow from UK stocks, likely makes the winners on AIM 10x more than 5x. Not great for companies who’ll seek more capital and probably dilute, great for shareholders when a stellar RNS is announced. Caveat emptor.
3 Likes
1 Like
1 Like
3 Likes
Hopefully tomorrow they give us a proper RNS
In what sense ?or expectation? Or hope
Just hoping they had forgotten to mention CE approval, desperation kicking in 
2 Likes
There no hope, they haven’t forgotten the CE they have no plans for it, just take your money.
Is that IMHO because I will wait for confirmation by RNS before I make any decision to sell out ?
Taken from the RNS dated April 30th 2024, admittedly they haven’t achieved all that they had hoped for but we haven’t been informed of a change of plan.
Future Outlook and Strategic Vision for 2024:
As we move into 2024, Kanabo is poised for a pivotal year. We believe we are strategically positioned to leverage our expanded product portfolio and enhanced distribution networks to meet the growing demand for digital health services and specialised medicines. Key initiatives include:
- Developing a streamlined triage process through a smart IT solution, enhancing our digital health platform;
- Expanding our in-pharmacy clinic franchise, increasing accessibility and reach;
- Launching and expanding our VapePod MD medical inhaler distribution in Germany; and
- Launching a SaaS solution for the Treat It platform, broadening our service capabilities and market reach.
In to the 60s 
Yes not a good place to be when you need a fund raise.
Kanabo better come up with something soon or they will run out of road.
1 Like
This from a retired GP
Suleman Sacranie posting on LinkedIn about scaling the GP service. Not much but in the absence of anything else.
2 Likes
Honestly if i wasnt so worried that the second i cut my losses and cashed out, the CE would come in and the share price would go up id cut my losses and run right now , its pretty grim viewing .
3 Likes
60% ish down for me. Would average down at these prices if I thought anything positive was coming, but complete lack of comms fill me with fear rather than confidence.
3 Likes
Large sell went through at .56p so there is no selling up here. Either they come up with something to stop the rot or this will be gone before the summer.
1 Like